Episode summary
Estée Lauder in Talks to Buy Puig to Create Beauty Giant | Bloomberg Intelligence
Bloomberg Intelligence
· · Hosts: Paul Sweeney, Scarlet Fu · Guests: Clara Hernanz Lizarraga, Steve Man, Jennifer Rie, Sam Fazeli
Summary
The episode centered first on reports that Estée Lauder is in talks to buy Puig Brands, a move that could create a beauty company with about $20 billion in annual sales. The guest said the deal would deepen Estée Lauder’s fragrance exposure, since Puig gets most of its revenue from perfumes and owns brands such as Rabanne, Jean Paul Gaultier and Carolina Herrera. But she also flagged strategy risk: Estée Lauder is already in reorganization mode, and its shares fell as investors questioned whether an acquisition fits its push toward niche, higher-end products.
The discussion then shifted to autos, where the analyst argued that a war-driven oil shock and recession risk could hurt demand. He said a worst-case scenario could mean a 15% drop in U.S. auto sales, even as higher fuel prices may help hybrids and battery EVs and benefit companies with more efficient lineups. The host and guest also noted that consumers may keep cars longer, boosting aftermarket parts sellers.
Later, the panel examined Nexstar’s Tegna deal, where federal regulators cleared the transaction but eight states sued to unwind it. The analyst said a full unwind looks unlikely, though divestitures remain possible. The episode closed with Pfizer’s Lyme disease vaccine data, with the guest saying 73% efficacy may not be enough to satisfy regulators or create a broad market.
Key takeaways
- The guest said a Puig acquisition would strengthen Estée Lauder’s fragrance business, which currently contributes about 17% of revenue.
- The host highlighted investor concern that Estée Lauder’s restructuring strategy may not match a large buyout of a family-controlled company.
- Steve Man said a severe oil shock and recession could cut U.S. auto sales by as much as 15%, even if hybrids and EVs gain share.
- Jennifer Rie said the legal risk to Nexstar’s Tegna deal is more likely to involve divestitures than a forced unwind.
- Sam Fazeli said Pfizer’s Lyme vaccine data at 73% efficacy raises questions about whether regulators will see it as strong enough.
Notable quotes
“it would help strengthen their position in this category of fragrances where they currently get about 17% of their revenues”
“the family owns most of the capital and mo and over 90% of their voting rights”
“worst case sales in the US could drop as much as 15%”
“the more likely outcome would be some divevestatures of stations”
How the episode opens
Bloomberg Audio Studios, podcasts, radio, news. You're listening to the Bloomberg Intelligence Podcast. Catch us live weekdays at 10 a.m. Eastern on Apple CarPlay and Android Auto with the Bloomberg Business App. Listen on demand wherever you get your podcasts or watch us live on YouTube.
Kind of a merger Tuesday, if you will. Estee Lauder Companies is in talk to buy Puj Brands in a deal that would create a cosmetic giant with about $20 billion in annual sales. Here, let's get some more details on this transaction.
We're joined by Claraara Lizaraga. She is companies reporter for Bloomberg News. She is based in Madrid.
Clara, tell us a little bit about Puj Brands. Who are they and why do you think Estee Lauder is in talks to acquire them? Hi Paul, thank you for having me.
So um poo unlike Estee Lauder gets most of its revenues from fragrances. It owns major brands like Kolina, Rodan, Jean Pauli and these are brands that have products that have consistently been amongst the top 10 bestselling fragrances. So for Estee Lauder, it would help strengthen their position in this category of fragrances where they currently get about 17% of their revenues.
And as you said, it would create a much larger company with a stronger exposure to Europe and Latin America and help it compete um more efficiently against rivals like L'Oreal L'Oreal for example. So Clara, I guess the thing with SA Lauder is that this is a company in reorganization mode. It's got this plan to focus on niche luxury priced fragrances.
Does buying pooch fit into that very specific strategy?
Well, exactly. So this is uh these are some of the questions that have um that have been asked today. So whether this is the right time for a sailor because um they're in the middle of streamlining operations.
From the episode’s captions: roughly the first two minutes, lightly cleaned. Keep watching on YouTube →
Topics
- beauty m&a
- auto sales recession risk
- brent crude oil
- biotech lyme vaccine
- broadcast deal legal risk
Companies and tickers mentioned
- EL
- TM
- TSLA
- RIVN
- NXST
- PFE
- Estée Lauder
- Puig
- Toyota
- Tesla
- Rivian
- Nexstar
- Tegna
- DirecTV
- Pfizer
Watch the episode
Summary, takeaways and quote selection by Octagon. Quotes are short excerpts; the full conversation is in the episode.
More from Bloomberg Intelligence
-
Anthropic’s IPO Is Said to Be About Six Times Oversubscribed | Bloomberg Intelligence -
Instant Reaction: Nvidia CEO Jensen Huang Ousted by Nvidia Board | Bloomberg Intelligence -
Nvidia’s Huang Ousted by Board in Move That Roils AI Economy | Bloomberg Intelligence -
CoreWeave Shares Soar After AI Computing Firm Eases Debt Fears | Bloomberg Intelligence -
Anthropic Targets $1.4 Trillion Valuation in Blockbuster IPO | Bloomberg Intelligence -
Nvidia Probe Into CEO Affair Raises Thorny Questions for AI | Bloomberg Intelligence
Bloomberg Intelligence, this episode and its artwork belong to Bloomberg. Octagon is not affiliated with the show; this page is an independent summary.
